# Study of VEGF-A Targeting NIR-II Fluorescence Endoscopy in the Gastrointestinal Tract

> **NCT06430372** · PHASE1 · RECRUITING · sponsor: **Institute of Automation, Chinese Academy of Sciences** · enrollment: 30 (estimated)

## Conditions studied

- Gastrointestinal Carcinoma
- Dysplasia
- Gastrointestinal Polyp

## Interventions

- **DRUG:** Bev-ICG
- **DEVICE:** NIR-II fluorescence endoscopy platform

## Key facts

- **NCT ID:** NCT06430372
- **Lead sponsor:** Institute of Automation, Chinese Academy of Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-07-20
- **Primary completion:** 2025-05-30
- **Final completion:** 2026-05-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06430372

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06430372, "Study of VEGF-A Targeting NIR-II Fluorescence Endoscopy in the Gastrointestinal Tract". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06430372. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*